Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Synergy Pharma Cmn (NASDAQ: SGYP)

$3.69 USD -$0.05 (-1.34%)
Last Price $3.69
Net Change $-0.05 (-1.34%)
Bid $3.56
Ask Price $3.77
Open Price $3.77
Previous Close Price $3.74
High Price $3.81
Low Price $3.63
Number of Trades 11,602
Volume 3,768,634
Fifty Two Week High $7.15 (2017-01-31)
Fifty Two Week Low $3.35 (2016-07-15)
Average Daily Volume 6,247,940
Share Outstanding 224,950 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $41.6
Recent Earnings $
Annual EPS $-1.06
Last Quarter EPS $
Market Capitalization $0.83B
Insider Shareholders % 0.036%
Annual Revenue $0B
No. Shares Outstanding 224,950
Inst. Shareholder % 67.59%
Annual Net Income $-0.2B
TTM Net Profit Margin $-203270
1-Year Return 5.35%
3-Year Return -9.88%
5-Year Return -17.26%
5-Year Revenue Growth 0%
5-Year Earnings Growth 303.33%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 41.599998%
Dividends per Share $
Stock Split Ratio 1-2
Beta 947.72
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.